GESTIÓN EN SALUD PÚBLICA: FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) | FDA

lunes, 1 de agosto de 2022

FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) | FDA

FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)